Related Experiment Videos
MEN-2A syndrome and pulmonary metastasis
J J Alfaro1, C Lamas, J Estrada
1Division of Endocrinology and Nutrition, Clínica Puerta de Hierro, Madrid, Spain. jalfaro@arrakis.es
Postgraduate Medical Journal
|January 18, 2002
Summary
Multiple Endocrine Neoplasia syndrome type 2A (MEN-2A) can present with rare parathyroid carcinoma. This case highlights the importance of considering parathyroid carcinoma in MEN-2A patients with unexplained hypercalcemia and pulmonary nodules.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Multiple Endocrine Neoplasia syndrome type 2A (MEN-2A) is a rare genetic disorder characterized by medullary thyroid carcinoma, pheochromocytoma, and parathyroid hyperplasia/adenoma.
- Primary hyperparathyroidism is common in MEN-2A, typically due to parathyroid hyperplasia or adenoma.
Observation:
- A patient with MEN-2A and medullary thyroid carcinoma initially treated with surgery presented with pulmonary nodules and hypercalcemia six years later.
- The pulmonary nodules were initially suspected to be medullary thyroid carcinoma metastases, and hypercalcemia attributed to persistent parathyroid disease.
Findings:
- Re-operation revealed the pulmonary nodules to be metastases from a parathyroid carcinoma.
- This represents a very rare manifestation of parathyroid carcinoma within the context of MEN-2A syndrome.
Implications:
- This case underscores the critical need to consider parathyroid carcinoma in the differential diagnosis of MEN-2A patients with recurrent or persistent hypercalcemia and suspicious pulmonary lesions.
- Accurate diagnosis is crucial for appropriate management and improved patient outcomes in rare endocrine neoplasia syndromes.